Vincent Caillet
Overview
Explore the profile of Vincent Caillet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
197
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Enjeti A, Ashraf A, Caillet V, Alam A, Silar J, Keer H, et al.
EJHaem
. 2024 Jun;
5(3):527-534.
PMID: 38895081
Hypomethylating agents are the most widely used upfront therapy for patients with myelodysplastic syndrome (MDS) who are not suitable for hematopoietic stem cell transplantation. In Australia, azacitidine was, until recently,...
2.
Coleshill M, Day R, Tam K, Kouhkamari M, Caillet V, Aung E, et al.
Br J Clin Pharmacol
. 2022 Jun;
88(11):4894-4901.
PMID: 35675118
Aim: Gout is the most common form of inflammatory arthritis in men. Despite the availability of effective urate-lowering therapies (ULT), the management of gout is suboptimal due to poor persistence...
3.
Hardcastle N, Briggs A, Caillet V, Angelis G, Chrystall D, Jayamanne D, et al.
Med Phys
. 2021 Feb;
48(6):2724-2732.
PMID: 33626183
Background: Fiducial markers are used as surrogates for tumor location during radiation therapy treatment. Developments in lung fiducial marker and implantation technology have provided a means to insert markers endobronchially...
4.
Zwan B, Caillet V, Booth J, Colvill E, Fuangrod T, OBrien R, et al.
Med Phys
. 2020 Dec;
48(3):953-964.
PMID: 33354787
Purpose: In multileaf collimator (MLC) tracking, the MLC positions from the original treatment plan are continuously modified to account for intrafraction tumor motion. As the treatment is adapted in real...
5.
Caillet V, Zwan B, Briggs A, Hardcastle N, Szymura K, Prodreka A, et al.
Phys Med Biol
. 2020 Dec;
65(23):235040.
PMID: 33263318
Purpose: The purpose of this work was to report on the geometric uncertainty for patients treated with multi-leaf collimator (MLC) tracking for lung SABR to verify the accuracy of the...
6.
Booth J, Caillet V, Briggs A, Hardcastle N, Angelis G, Jayamanne D, et al.
Radiother Oncol
. 2020 Nov;
155:131-137.
PMID: 33152399
Background And Purpose: The purpose of this work is to present the clinical experience from the first-in-human trial of real-time tumor targeting via MLC tracking for stereotactic ablative body radiotherapy...
7.
Steiner E, Shieh C, Caillet V, Booth J, OBrien R, Briggs A, et al.
Radiother Oncol
. 2019 Apr;
135:65-73.
PMID: 31015172
Background And Purpose: To test the hypothesis that 4DCT and 4DCBCT-measured target motion ranges predict target motion ranges during lung cancer SABR. Materials And Methods: Ten lung SABR patients were...
8.
Alnaghy S, Kyme A, Caillet V, Nguyen D, OBrien R, Booth J, et al.
Phys Med Biol
. 2019 Apr;
64(10):105021.
PMID: 30986773
In this study we develop and characterise a six degree-of-freedom (6 DoF) robotic motion system for quality assurance of real-time image-guided radiotherapy techniques. The system consists of a commercially available...
9.
Caillet V, OBrien R, Moore D, Poulsen P, Pommer T, Colvill E, et al.
Med Phys
. 2019 Feb;
46(4):1814-1820.
PMID: 30719723
Purpose: Multileaf collimator (MLC) tracking is being clinically pioneered to continuously compensate for thoracic and pelvic motion during radiotherapy. The purpose of this work was to characterize the performance of...
10.
Lydiard S, Caillet V, Ipsen S, OBrien R, Blanck O, Poulsen P, et al.
Phys Med Biol
. 2018 Sep;
63(19):195008.
PMID: 30189419
Stereotactic arrhythmia radioablation (STAR) is an emerging treatment option for atrial fibrillation (AF). However, it faces possibly the most challenging motion compensation scenario: both respiratory and cardiac motion. Multi-leaf collimator...